C

COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A.U.

20 employees

Columbus Venture Partners is an independent venture capital that invests in early-stage opportunities in the life science industry.

Investor insights

Sectors invested in

Biotechnology8
Health Care8
Medical3
Biopharma3
Pharmaceutical3
Genetics2
Therapeutics2
drug development2
research2
nanotechnology2
biotechnology2
Rare diseases1
Friedreich's Ataxia1
X-linked Adrenoleukodystrophy1
Orphan CNS1
Neurometabolic diseases1

Funding rounds participated in

$29M sweet spot round size

Most of their 9 investments are in rounds between $26M and $55M

Investor type

Venture Capital

Basic info

Industry

investment management

Date founded

2015

Investments made

M

Minoryx Therapeutics raised $55M on May 31, 2022

Investors: Ysios Capital, FundPlus, CDTI, Centre for the Development of Industrial Technology and COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A.U.

A

Artax Biopharma Inc raised $26M on May 11, 2022

Investors: Sound Bioventures and COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A.U.

I

Integra Therapeutics raised $1.7M on March 29, 2022

Investors: COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A.U.

N

NERRE THERAPEUTICS LTD raised $28M on July 7, 2021

Investors: OrbiMed Advisors, Forbion, Advent Life Sciences and COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A.U.

A

Aura Biosciences raised $80M on March 22, 2021

Investors: Chiesi Ventures, Lundbeckfonden / Lundbeck Foundation, Arix Bioscience plc, Advent Life Sciences, Ysios Capital, Surveyor Capital, Medicxi and COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A.U.

B

BiOncotech Therapeutics raised $27M on February 4, 2021

Investors: Advent Life Sciences, CDTI, Centre for the Development of Industrial Technology and COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A.U.

A

Artax Biopharma Inc raised undisclosed on June 4, 2020

Investors: COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A.U.

U

Undisclosed raised $63M on June 26, 2019

Investors: Alta Life Sciences, Lundbeckfonden / Lundbeck Foundation, Andera Partners, Ysios Capital, Forbion, Gilde Healthcare, Healthequity, SCR and COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A.U.

A

Aura Biosciences raised $30M on December 21, 2017

Investors: Chiesi Ventures, Lundbeckfonden / Lundbeck Foundation, Arix Bioscience plc, Ysios Capital, Advent Life Sciences, LI-COR Biosciences and COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A.U.

FAQ